Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

GlaxoSmithKline

GSK takes lead role in UK personalised medicine programme

May 20, 2011 Research and Development AstraZeneca, GlaxoSmithKline, Ig Innovations, Janssen, Randox Laboratories, personalised medicine

The first cheque has been written for the government-backed Stratified Medicine Innovation Platform (SMIP), set up last year to pump …
News

Pfizer’s cancer drug meets end points in head-to-head study

May 20, 2011 Research and Development, Sales and Marketing Pfizer, axitinib, rcc

Pfizer’s investigational cancer drug axitinib significantly increased survival in kidney cancer patients when compared to Bayer’s standard treatment Nexavar. New …
News

Blood cancer charity to kick-start clinical trials

May 19, 2011 Research and Development Cancer, blood cancer, clinical trials, leukaemia

A UK blood cancer charity is creating a network of clinical trial centres with backing from the NIHR Clinical Research …
News
Roche

MetMab produces exciting results in lung cancer patients

May 19, 2011 Research and Development MetMAb, Roche

Roche’s MetMab has shown huge promise in phase II trials in lung cancer – but only in patients with ‘high …
News
Takeda headquarters

Takeda buys Nycomed for $13.6bn

May 19, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Nycomed, Takeda

Takeda has acquired Swiss specialist pharma firm Nycomed, boosting its presence in emerging markets. The deal comes in at 9.6 …
News
Shire UK

Shire makes $750m regenerative medicines acquisition

May 18, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Shire, regenerative medicine

Shire’s ambitions to build a regenerative medicine business will soon be realised following its $750 million acquisition of Advanced BioHealing. …
News

Mark Dean-Netscher joins Penn Pharma

May 18, 2011 Manufacturing and Production, Research and Development appointment, manufacturing and production, research and development

Penn Pharma has appointed Mark Dean-Netscher as its new chief operating officer. He has more than 20 years experience in …
Appointment

Sanofi strikes Crohn’s deal with Glenmark

May 16, 2011 Research and Development Crohn’s disease, Glenmark, Sanofi

Sanofi has signed a deal with Indian drug maker Glenmark Pharmaceuticals to develop a new treatment for Crohn’s Disease. The …
News
ABPI's London offices

ABPI and BIA move in together

May 16, 2011 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, BIA

The UK’s pharma industry association the ABPI and its biotech equivalent the BIA are jointly relocating to new London offices. …
News

It’s time we redesigned the clinical trial

May 16, 2011 Research and Development clinical trials, randomised controlled trials

Who can remember a time when the pathway from laboratory bench to marketed product didn’t include clinical trial phases I …
Feature

Takeda denies $12bn Nycomed takeover reports

May 13, 2011 Research and Development, Sales and Marketing Nycomed, Takeda

Japan’s biggest pharma firm Takeda has denied reports it is negotiating a billion dollar deal to acquire Swiss speciality firm …
News
European Parliament

EMA under fire from European Parliament

May 13, 2011 Medical Communications, Research and Development, Sales and Marketing EMA, European Parliament, MEPs

The EMA has been hit by a barrage of criticism from the European Parliament over conflicts of interest and the …
News
GlaxoSmithKline

GSK and AZ collaborate on translational research centre

May 12, 2011 Research and Development AstraZeneca, GlaxoSmithKline, The University of Manchester, academic research, translational research

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research …
News

Government wrong to push for Avastin in eye disease, says charity

May 12, 2011 Research and Development, Sales and Marketing Lucentis, RNIB, avastin, wet AMD

The UK government’s pursuit of Avastin for use in ophthalmology is bad for patients, says the Royal National Institute of …
News

AZ signs targeted colon cancer drug collaboration

May 11, 2011 Research and Development AstraZeneca, colorectal cancer, personalised medicine

AstraZeneca has entered a partnership which intends to speed up the development of targeted treatments for colorectal cancer, a disease …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026